VivoSeq
Other

Vertigo

20

Pipeline Programs↗

5

Active Trials↗

8

Companies Involved↗

Vertigo is an emerging landscape with 20 programs across 8 companies. The most active players are Sihuan Pharmaceutical Holdings Group Ltd., Amgen, Bristol-Myers Squibb. 7 therapies are approved with 6 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

47/100

Pipeline Velocity

6/100

Mech. Concentration

25/100

Completion Rate

82/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

Sihuan Pharmaceutical Holdings Group Ltd.

1 program

Phase 2Amgen logo

Amgen

1 program

Phase 2Bristol-Myers Squibb logo

Bristol-Myers Squibb

1 program

Phase 3Alnylam Pharmaceuticals logo

Alnylam Pharmaceuticals

1 program

Phase 3Akero Therapeutics logo

Akero Therapeutics

1 program

ApprovedV

Validus Pharmaceuticals

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

18

clinical trials

Completed9 · 50%
Recruiting5 · 28%
Unknown status2 · 11%
Terminated1 · 6%
Withdrawn1 · 6%

Clinical Trials

Trial Activity

18 trials

Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.
Recruiting·OOman Medical Speciality Board·Phase 3·NCT05586763·90 enrolled
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
Recruiting·LLeiden University Medical Center·Phase 3·NCT05851508·148 enrolled
Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo
Recruiting·VValenta Pharm JSC·Phase 4·NCT06321341·160 enrolled
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
Recruiting·SSeoul National University Hospital·Phase 1/2·NCT06001593·120 enrolled
Evaluation of Nystagmus Examinations Conducted Using Wearable Augmented Reality Glasses in Vertigo Patients: A Randomized Equivalence Study
Recruiting·CChang Gung Memorial Hospital·Preclinical·NCT07238387·200 enrolled
Promethazine vs. Lorazepam for Treatment of Vertigo
Completed·SShahid Beheshti University of Medical Sciences·Phase 3·NCT01827293·210 enrolled
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
Completed·LLehigh Valley Hospital·N/A·NCT00641797·26 enrolled
Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin
Completed·—·Phase 3·NCT02112578·292 enrolled
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
Completed·FFundação Educacional Serra dos Órgãos·Phase 4·NCT05221892·334 enrolled
Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo
Completed·PPamukkale University·Phase 4·NCT02253524·200 enrolled
Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo
Completed·UUniversitas Sebelas Maret·Phase 4·NCT07075289·44 enrolled
Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo
Completed·VValenta Pharm JSC·Phase 3·NCT05430217·268 enrolled
A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo
Completed·SSihuan Pharmaceutical Holdings Group Ltd.·Phase 2·NCT02299804·98 enrolled
Effect of V0251 in Acute Vertigo
Completed·PPierre Fabre Medicament·Phase 2·NCT01583738·132 enrolled
Trental for the Treatment of Vertigo/Dizziness/Imbalance
Terminated·UUniversity of Missouri-Columbia·N/A·NCT02592863·26 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)